Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 10 Issue 5, May 2009

Experimental autoimmune encephalomyelitis requires the entry of disease-inducing T cells into the brain. Reboldi and colleagues (p 514; see also News and Views by Steinman, p 453) find that TH-17 cells initiate this disease by entering the brain through the choroid plexus. The original image shows human brain tissue in which choroid plexus epithelial cells are stained with antibody to CCL20 (fuchsia) and astrocytes are 'decorated' by antibody to glial fibrillary acidic protein (brown). Original image by Andrew Elston (LifeSpan BioSciences). Artwork by Lewis Long.

Editorial

  • Over 20 years ago, the Global Polio Eradication Initiative was launched. Today, polio is still endemic in four countries.

    Editorial

    Advertisement

Top of page ⤴

Essay

Top of page ⤴

News & Views

  • How the immune system responds to local infection and establishes protective immunity in susceptible tissues remains unclear. Two new studies show that local tissue-resident dendritic cells prime cytotoxic T lymphocyte responses and that memory cytotoxic T lymphocytes remain in the tissue to provide antiviral immunity.

    • Akiko Iwasaki
    News & Views
  • Little is known about how pathogenic T cells gain access to the uninflamed brain in multiple sclerosis and experimental autoimmune encephalomyelitis. A new study reports that interleukin 17–producing T helper cells enter the uninflamed central nervous system through the choroid plexus by a CCR6-CCL20–dependent mechanism.

    • Robert C Axtell
    • Lawrence Steinman
    News & Views
  • The 3020insC mutation in Nod2 is associated with Crohn's disease, but how it influences disease pathogenesis is unknown. A new study shows that the 3020insC mutant protein fails to activate a key transcription factor that drives interleukin 10 expression, resulting in reduced production of this anti-inflammatory cytokine.

    • Dana J Philpott
    • Stephen E Girardin
    News & Views
Top of page ⤴

Research Highlights

Top of page ⤴

Review Article

Top of page ⤴

Article

Top of page ⤴

Corrigendum

Top of page ⤴

Erratum

Top of page ⤴

Search

Quick links